Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking ...
We I looked at Akorn, Inc. (NASDAQ:AKRX)’s historical hedge fund sentiment chart I noticed that AKRX was an extremely popular stock among hedge funds 4-5 years ago. It was trading at $40 per share ...
Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Akorn (AKRX) and Amphastar Pharmaceuticals (AMPH). But which of these two stocks offers value investors a ...
Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Teva Pharmaceutical Industries Ltd. (TEVA) and Akorn (AKRX). But which of these two stocks is more attractive ...
As of late, it has definitely been a great time to be an investor in Akorn, Inc. AKRX. The stock has moved higher by 9.5% in the past month, while it is also above its 20 Day SMA too. This combination ...
It's not possible to invest over long periods without making some bad investments. But you want to avoid the really big losses like the plague. So take a moment to sympathize with the long term ...
Investors in Akorn Inc (NASD: AKRX) saw new options begin trading this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AKRX options ...
Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. The put contract at the $22.50 strike price has a current bid of 45 cents. If ...
Investors looking for stocks in the Medical - Generic Drugs sector might want to consider either Akorn (AKRX) or Amphastar Pharmaceuticals (AMPH). But which of these two stocks presents investors with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results